Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma
@article{TAU70141, author = {Xiaolin Lu and Weijie Gu and Guohai Shi and Dingwei Ye}, title = {Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma}, journal = {Translational Andrology and Urology}, volume = {10}, number = {5}, year = {2021}, keywords = {}, abstract = {}, issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/70141} }